We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva, Glenmark Resolve Coreg Patent Dispute
Teva, Glenmark Resolve Coreg Patent Dispute
April 28, 2009
Teva Pharmaceutical Industries and Glenmark Generics have reached an agreement to resolve patent infringement litigation related to GlaxoSmithKline's (GSK) heart drug Coreg.